For the year ending 2025-12-31, SOLV had $116M increase in cash & cash equivalents over the period. -$10M in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income | 1,556 | 479 |
| Depreciation and amortization | 489 | 555 |
| Pension and postretirement benefit expense | 62 | 34 |
| Stock-based compensation expense | 161 | 112 |
| Gain on sale of business | 1,549 | 0 |
| Transaction costs | -111 | - |
| Deferred income taxes | -120 | -155 |
| Accounts receivable | -34 | -43 |
| Due from related parties | -44 | -233 |
| Inventories | 139 | 132 |
| Accounts payable | 104 | 266 |
| Due to related parties | -11 | -565 |
| Accrued compensation | 43 | - |
| All other operating activities - net | -194 | 315 |
| Net cash provided by operating activities | 369 | 1,185 |
| Purchases of property, plant and equipment | 379 | 380 |
| Acquisitions, net of cash acquired | 696 | - |
| Proceeds from sale of business | 3,890 | 0 |
| Other net | 18 | 0 |
| Net cash provided by (used in) investing activities | 2,797 | -380 |
| Repayment of debt | 3,070 | 300 |
| Net transfers to 3m | 33 | 8,251 |
| Proceeds from long-term debt, net of issuance costs | 0 | 8,303 |
| Other net | 46 | 8 |
| Net cash used in financing activities | -3,057 | -240 |
| Effect of exchange rate changes on cash and cash equivalents | 7 | 3 |
| Net increase (decrease) in cash and cash equivalents | 116 | 568 |
| Cash and cash equivalents at beginning of year | 762 | 194 |
| Cash and cash equivalents at end of year | 878 | 762 |
Solventum Corp (SOLV)
Solventum Corp (SOLV)